Literature DB >> 21303239

Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.

Samuel M Jenness1, Holly Hagan, Kai-Lih Liu, Travis Wendel, Christopher S Murrill.   

Abstract

Sterile syringe access is an important means to reduce HIV risk, but many injection drug users (IDU) who obtain syringes from sterile sources continue to share syringes. We examined the factors associated with continuing syringe sharing in New York City. We recruited 500 active IDU in 2005 through respondent-driven sampling. In multiple logistic regression, not obtaining all syringes in the past year exclusively from sterile sources was associated with increased syringe sharing. Ensuring adequate syringe availability as well as engaging and retaining nonusers and inconsistent users in sterile syringe services may increase sterile syringe access and decrease syringe sharing.

Entities:  

Mesh:

Year:  2011        PMID: 21303239      PMCID: PMC4797646          DOI: 10.3109/10826084.2011.521467

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  70 in total

Review 1.  Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy.

Authors:  D Vlahov; D C Des Jarlais; E Goosby; P C Hollinger; P G Lurie; M D Shriver; S A Strathdee
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

2.  Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.

Authors:  N U Cotten-Oldenburg; P Carr; J M DeBoer; E K Collison; G Novotny
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

3.  Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.

Authors:  Samuel R Friedman; Hannah Lf Cooper; Barbara Tempalski; Maria Keem; Risa Friedman; Peter L Flom; Don C Des Jarlais
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

Review 4.  Review of sampling hard-to-reach and hidden populations for HIV surveillance.

Authors:  Robert Magnani; Keith Sabin; Tobi Saidel; Douglas Heckathorn
Journal:  AIDS       Date:  2005-05       Impact factor: 4.177

5.  Distributive syringe sharing among young adult injection drug users in five U.S. cities.

Authors:  Elizabeth T Golub; Steffanie A Strathdee; Susan L Bailey; Holly Hagan; Mary H Latka; Sharon M Hudson; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2007-03-29       Impact factor: 4.492

6.  Injection drug users report good access to pharmacy sale of syringes.

Authors:  Wendy Reich; Wilson M Compton; Joeseph C Horton; Linda B Cottler; Renee M Cunningham-Williams; Robert Booth; Merrill Singer; Carl Leukefeld; Joseph Fink; Tom J Stopka; Karen Fortuin Corsi; Michelle Staton Tindall
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

7.  Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.

Authors:  Jeffrey Rothman; Diane Rudnick; Marc Slifer; Bruce Agins; Karl Heiner; Guthrie Birkhead
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

8.  "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

9.  Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.

Authors:  Don C Des Jarlais; Naomi Braine; Huso Yi; Charles Turner
Journal:  AIDS Educ Prev       Date:  2007-04

10.  Women's drug injection practices in East Harlem: an event analysis in a high-risk community.

Authors:  Stephanie Tortu; James M McMahon; Rahul Hamid; Alan Neaigus
Journal:  AIDS Behav       Date:  2003-09
View more
  5 in total

1.  Current and emerging research needs in studying the NYC HIV-drug use epidemic.

Authors:  Sherry Deren; Holly Hagan; Samuel Friedman; Don C Des Jarlais; David Perlman; Marya Gwadz; Charles Cleland; Andrew Osborne; Joseph Lunievicz
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

2.  Novel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York City.

Authors:  Arpi S Terzian; Sara D Bodach; Ellen W Wiewel; Kent Sepkowitz; Marie-Antoinette Bernard; Sarah L Braunstein; Colin W Shepard
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

3.  Estimating Hidden Population Sizes with Venue-based Sampling: Extensions of the Generalized Network Scale-up Estimator.

Authors:  Ashton M Verdery; Sharon Weir; Zahra Reynolds; Grace Mulholland; Jessie K Edwards
Journal:  Epidemiology       Date:  2019-11       Impact factor: 4.822

4.  Web-Based Eligibility Quizzes to Verify Opioid Use and County Residence Among Rural Young Adults: Eligibility Screening Results from a Feasibility Study.

Authors:  April M Ballard; Hannah Lf Cooper; April M Young
Journal:  JMIR Res Protoc       Date:  2019-06-18

5.  Optimal allocation of HIV prevention funds for state health departments.

Authors:  Emine Yaylali; Paul G Farnham; Stacy Cohen; David W Purcell; Heather Hauck; Stephanie L Sansom
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.